Clinical trial
Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis
NCT04741464 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 2, 2021
- Completion date
- November 30, 2025
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
deep vein thrombosis, inflammatory response